HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.

Abstract
The chemoattractant protein 1 (MCP-1) is one of the most potent monocyte chemoattractants whose level is elevated during the course of AIDS dementia. Earlier studies showed that HIV-1 Tat protein is able to induce transcription of the MCP-1 promoter in astrocytic cells. Furthermore, the TGFbeta-1 signaling pathway through its regulatory proteins, Smads, modulates Tat activation of MCP-1. Here, we demonstrate that C/EBPbeta, whose activity is enhanced by a variety of cytokines during the course of viral infection, can stimulate basal- and Tat-mediated transcription of MCP-1 in human astrocytic cells. Results using promoter deletion mutants suggested the importance of multiple C/EBPbeta binding sites scattered within -200 to +1 of the MCP-1 promoter in the observed activity. Results from DNA binding studies have shown that the interaction of C/EBPbeta with its DNA motif is diminished by the C/EBPbeta homologous protein, CHOP, which possesses the ability to suppress the stimulatory effect of C/EBPbeta on MCP-1 transcription. Tat, which possesses the ability to interact with C/EBPbeta, alleviates the negative effect of CHOP and restores C/EBPbeta interaction with the DNA. Furthermore, Smad3 and its C-terminal regulatory motif, MH2, interact with C/EBPbeta and modulate its DNA binding and transcriptional activity on the MCP-1 promoter. Our results show that the physical and functional interactions of C/EBPbeta and Tat are severely affected by the presence of Smad3 and MH2. Altogether, these observations identify C/EBPbeta as a new partner for Tat in stimulating MCP-1 transcription in astrocytes and suggest that the delicate balance among the downstream regulatory proteins of several cytokines and immunomodulators can dictate the level of expression of chemoattractants, including MCP-1. Hence, inappropriate expression and function of regulatory proteins such as C/EBPbeta and Smads by Tat may induce MCP-1 production in astrocytes and contribute to the neuropathogenesis of AIDS through stimulation of inflammation in the CNS.
AuthorsSelvajothi Abraham, Thersa Sweet, Bassel E Sawaya, Jay Rappaport, Kamel Khalili, Shohreh Amini
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 160 Issue 1-2 Pg. 219-27 (Mar 2005) ISSN: 0165-5728 [Print] Netherlands
PMID15710476 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CCAAT-Enhancer-Binding Protein-beta
  • CCAAT-Enhancer-Binding Proteins
  • Chemokine CCL2
  • DDIT3 protein, human
  • DNA-Binding Proteins
  • Gene Products, tat
  • Recombinant Fusion Proteins
  • SMAD3 protein, human
  • Smad3 Protein
  • Trans-Activators
  • Transcription Factors
  • Transforming Growth Factor beta
  • tat Gene Products, Human Immunodeficiency Virus
  • Transcription Factor CHOP
  • Glutathione Transferase
Topics
  • Active Transport, Cell Nucleus (genetics)
  • Amino Acid Motifs (genetics)
  • Astrocytes (immunology, metabolism, virology)
  • CCAAT-Enhancer-Binding Protein-beta (metabolism, physiology)
  • CCAAT-Enhancer-Binding Proteins (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Nucleus (genetics, metabolism)
  • Chemokine CCL2 (genetics, metabolism)
  • DNA-Binding Proteins (genetics, physiology)
  • Gene Products, tat (metabolism, physiology)
  • Glutathione Transferase (genetics)
  • HIV-1 (immunology)
  • Humans
  • Promoter Regions, Genetic
  • Protein Structure, Tertiary (genetics)
  • Recombinant Fusion Proteins (genetics)
  • Sequence Deletion
  • Signal Transduction (genetics, immunology)
  • Smad3 Protein
  • Trans-Activators (genetics, physiology)
  • Transcription Factor CHOP
  • Transcription Factors (genetics, metabolism)
  • Transfection
  • Transforming Growth Factor beta (physiology)
  • tat Gene Products, Human Immunodeficiency Virus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: